ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,415
0,27%
Bitcoin
60 994,90
-1,32%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Bicycle Therapeutics PLC (BCYC)

  7. Bicycle Therapeutics PLC (BCYC) Actualités

BCYC

Bicycle Therapeutics (BCYC)

Bicycle Therapeutics PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BCYC
DateHeureSourceTitreSymboleSociété
18/06/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
18/06/202422h14Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:BCYCBicycle Therapeutics PLC
03/06/202413h00Business WireBicycle Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202423h05Business WireBicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
23/05/202413h00Business WireBicycle Therapeutics Announces $555 Million Private Placement Equity FinancingNASDAQ:BCYCBicycle Therapeutics PLC
02/05/202413h00Business WireBicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
24/04/202416h05Business WireBicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
02/04/202413h00Business WireBicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
05/03/202422h35Business WireBicycle Therapeutics to Present at the AACR Annual Meeting 2024NASDAQ:BCYCBicycle Therapeutics PLC
21/02/202422h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
21/02/202422h40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202414h38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BCYCBicycle Therapeutics PLC
20/02/202413h19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BCYCBicycle Therapeutics PLC
20/02/202413h05Business WireBicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BCYCBicycle Therapeutics PLC
14/02/202422h08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCYCBicycle Therapeutics PLC
07/02/202413h00Business WireBicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
03/01/202422h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
14/12/202313h00Business WireBicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D DayNASDAQ:BCYCBicycle Therapeutics PLC
30/11/202313h00Business WireBicycle Therapeutics to Host R&D Day on December 14NASDAQ:BCYCBicycle Therapeutics PLC
02/11/202312h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCYCBicycle Therapeutics PLC
02/11/202312h00Business WireBicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D DayNASDAQ:BCYCBicycle Therapeutics PLC
19/10/202313h00Business WireBicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder CancerNASDAQ:BCYCBicycle Therapeutics PLC
19/10/202310h00GlobeNewswire Inc.Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive DirectorNASDAQ:BCYCBicycle Therapeutics PLC
11/09/202317h08Dow Jones NewsBicycle Therapeutics Shares Rise 8% After Continuation of BT8009 DevelopmentNASDAQ:BCYCBicycle Therapeutics PLC
11/09/202313h00Business WireBicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder CancerNASDAQ:BCYCBicycle Therapeutics PLC
05/09/202313h00Business WireBicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
03/08/202312h59Business WireBicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BCYCBicycle Therapeutics PLC
18/07/202313h00Business WireBicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:BCYCBicycle Therapeutics PLC
13/07/202322h17Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCYCBicycle Therapeutics PLC
13/07/202304h23Business WireBicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary SharesNASDAQ:BCYCBicycle Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:BCYC

Dernières Valeurs Consultées

LSE
56BS
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés